Stocks and Investing Stocks and Investing
Tue, November 14, 2023

Jason Butler Maintained (VRDN) at Buy with Decreased Target to $38 on, Nov 14th, 2023


Published on 2024-10-28 07:34:19 - WOPRAI, Jason Butler
  Print publication without navigation


Jason Butler of JMP Securities, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $42 to $38 on, Nov 14th, 2023.

Jason has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Jason's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Jason


  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $37 on, Tuesday, October 31st, 2023
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $30 on, Monday, October 30th, 2023
  • Alex Thompson of "Stifel" Reiterated at Strong Buy and Held Target at $40 on, Wednesday, September 13th, 2023
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $37 on, Thursday, August 10th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 9th, 2023
Contributing Sources